Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-27

Clinical Trial Update: Pilot Study Evaluating The Efficacy Of Etanercept In Acute Gout [Phase 4]

View source ↗

Summary

Pilot Phase 4 trial evaluating etanercept for acute gout has been terminated; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etanercept (etanercept)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Gout Attack | Phase 4 | Status: TERMINATED | Results posted: 2023-10-27